ORIGINAL ARTICLES |
|
|
|
|
|
Dibohemamines I-O from Streptomyces sp. GZWMJZ-662, an endophytic actinomycete from the medicinal and edible plant Houttuynia cordata Thunb. |
Dong-Yang Wang1,2, Ming-Xing Li1,2, Yan-Chao Xu1,3, Peng Fu4, Wei-Ming Zhu1,4, Li-Ping Wang1,2 |
1. State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China; 2. Natural Product Research Center of Guizhou Province, Guiyang, 550014, China; 3. School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang, 561113, China; 4. School of Medicine and Pharmacy, Ocean University of China, Qingdao, 266003, China |
|
|
Abstract A chemical investigation of Streptomyces sp. GZWMJZ-662, an endophytic actinomycete isolated from Houttuynia cordata Thunb., has yielded eleven bohemamine dimers (1-11). Notably, the newly identified dibohemamines I–O (1-7) have not been previously reported. Their structures were elucidated through detailed spectroscopic analysis, encompassing high-resolution electrospray ionization mass, nuclear magnetic resonance, infrared radiation, ultraviolet–visible, and electronic circular dichroism spectroscopy. Dibohemamine I (1) exhibited selective cytotoxic effects against the cancer cell lines 786-O and GBC-SD among the 18 cell lines evaluated, with the half-inhibitory concentration values of 3.24±0.20 and 7.36±0.41 μM, respectively.
|
Keywords
Endophytic actinomycete
Secondary metabolite
Dibohemamine
Cytotoxicity
|
Fund:The National Natural Science Foundation of China,82460684,Li-Ping Wang, West Light Foundation, Chinese Academy of Sciences, RZ [2022]4, Li-Ping Wang, Research Foundation for Advanced Talents (D. Wang),TCZJZ [2022]02, Dong-Yang Wang, Project of State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, QJJ[2022]419, Peng Fu, Cultivation project of National Natural Science Foundation of Guizhou Medical University, 20NSP065, Li-Ping Wang, the 100 Leading Talents of Guizhou Province, W. Zhu, Wei-Ming Zhu. |
Corresponding Authors:
Wei-Ming ZHU,E-mail:weimingzhu@ouc.edu.cn;Li-Ping WANG,E-mail:wangliping2022@gmc.edu.cn
E-mail: weimingzhu@ouc.edu.cn;wangliping2022@gmc.edu.cn
|
Issue Date: 15 February 2025
|
|
|
[1] Selim MSM, Abdelhamid SA, Mohamed SS. Secondary metabolites and biodiversity of actinomycetes. Genet Eng Biotechnol. 2021;19:72. [2] Genilloud O. Actinomycetes: still a source of novel antibiotics. Nat Prod Rep. 2017;34:1203–32. [3] Schniete JK, Fernández-Martínez LT. Natural product discovery in soil actinomycetes: unlocking their potential within an ecological context. Curr Opin Microbiol. 2024;79: 102487. [4] Matsumoto A, Takahashi Y. Endophytic actinomycetes: promising source of novel bioactive compounds. J Antibiot (Tokyo). 2017;70(5):514–9. [5] Nalini MS, Prakash HS. Diversity and bioprospecting of actinomycete endophytes from the medicinal plants. Lett Appl Microbiol. 2017;64:261–70. [6] Ayswaria R, Vasu V, Krishna R. Diverse endophytic Streptomyces species with dynamic metabolites and their meritorious applications: a critical review. Crit Rev Microbiol. 2020;46:750–8. [7] Bernardi DI, das Chagas FO, Monteiro AF, Dos Santos GF, de Souza Berlinck RG. Secondary metabolites of endophytic actinomycetes: isolation, synthesis, biosynthesis, and biological activities. Prog Chem Org Nat Prod 2019; 108: 207–296. [8] Zotchev SB. Unlocking the potential of bacterial endophytes from medicinal plants for drug discovery. Microb Biotechnol. 2024;17: e14382. [9] Wei P, Luo Q, Hou Y, Zhao F, Li F, Meng Q. Houttuynia Cordata Thunb.: a comprehensive review of traditional applications, phytochemistry, pharmacology and safety. Phytomedicine. 2023;123:155195. [10] Das SK, Deka SJ, Paul D, Gupta DD, Das TJ, Maravi DK, Tag H, Hui PK. In-silico based identification of phytochemicals from Houttuynia cordata Thunb as potential inhibitors for overexpressed HER2 and VEGFR2 cancer genes. J Biomol Struct Dyn. 2022;40:6857–67. [11] Lou YM, Guo ZZ, Zhu YF, Kong MY, Zhang RR, Lu LL, Wu FC, Liu ZQ, Wu JJ. Houttuynia cordata Thunb and its bioactive compound 2-undecanone significantly suppress benzo(a)pyrene-induced lung tumori.genesis by activating the Nrf2-HO-1/NQO-1 signaling pathway. J Exp Clin Canc Res. 2019;38:242. [12] Inthi P, Pandith H, Kongtawelert P. Anti-cancer effect and active phytochemicals of Houttuynia cordata Thunb against human breast cancer cells. Asian Pac J Cancer Prev. 2023;24:1265–74. [13] Chen YF, Yang JS, Chang WS, Tsai SC, Peng SF, Zhou YR. Houttuynia cordata Thunb extract modulates G0/G1 arrest and Fas/CD95-mediated death receptor apoptotic cell death in human lung cancer A549 cells. J Biomed Sci. 2013;20:18. [14] Yin Y, Wang D, Wu D, He W, Zuo M, Zhu W, Xu Y, Wang L. Two new 4-Hydroxy-2-pyridone alkaloids with antimicrobial and cytotoxic activities from Arthrinium sp. GZWMJZ-606 endophytic with Houttuynia cordata Thunb. Molecules. 2023;28:2192. [15] Fu P, Legako A, La S, MacMillan JB. Discovery, characterization, and analogue synthesis of bohemamine dimers generated by non-enzymatic biosynthesis. Chem Eur J. 2016;22:3491–5. [16] Zhang R, Yan X, Yin S, Wang W, Zhu W, Fu P. Discovery of new bohemamines and synthesis of methylene-bridged chimeric derivatives through natural product chimera strategy. Chin J Chem. 2022;40:1413–21. [17] Jiang B, Zhao W, Li S, Liu H, Yu L, Zhang Y, He H, Wu L. Cytotoxic dibohemamines D-F from a Streptomyces Species. J Nat Prod. 2017;80:2825–9. [18] Bugni TS, Woolery M, Kauffman CA, Jensen PR, Fenical W. Bohemamines from a marine-derived Streptomyces sp. J Nat Prod. 2006;69:1626–8. [19] Ueda JY, Hashimoto J, Nagai A, Nakashima T, Komaki H, Anzai K, Harayama S, Doi T, Takahashi T, Nagasawa K, Natsume T, Takagi M, Shin-ya K. New aureothin derivative, alloaureothin, from Streptomyces sp MM23. J Antibiot (Tokyo). 2007;60:321–4. [20] Wang L, He W, Wang X, Li G, Wang D, Xu Y, Zhu W. Asteriquinones from Aspergillus sp. GZWMJZ-258 and their derivatives. J Nat Prod. 2023;86:2522–8. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|